SCIENCE AT THE SPEED OF BUSINESS

Our fundamental premise is that innovative methods, analytical rigor, and scientific acumen can be provided in a commercial entity that operates “at the speed of business.” Monument Analytics delivers.

Unparalleled Knowledge Base

One of the most remarkable features of Monument Analytics is its access to consultants with an unparalleled knowledge base. Through its independent consulting services, Monument Analytics leverages this acumen to assist clients developing products and services for the benefit of society.

Top Notch Evidence

By capitalizing on this unparalleled depth and breadth of human capital, Monument Analytics is able to generate the highest quality evidence regarding the safety, effectiveness, and real-world value of the full range of medical processes and technologies; and to use this knowledge to help our clients navigate evermore complex and challenging regulatory and payment environments.

Internationally Renowned Experts

Our Principals and Consultants are internationally renowned for their expertise in areas ranging from epidemiology and biostatistics to clinical fields such as cardiovascular medicine, oncology, and immunology.

G. Caleb Alexander
G. Caleb AlexanderMD, MS
CO-FOUNDER & PRINCIPAL
Jonothan C. Tierce
Jonothan C. TierceCPhil
CO-FOUNDER & PRINCIPAL
William V. Padula
William V. PadulaPhD
PRINCIPAL
Natalie Reid
Natalie ReidPhD, MPH, MBA
DIRECTOR
MEET THE CONSULTING TEAM

Services

Our services are broadly organized into four core capabilities

  • Comparative effectiveness analyses
  • Pharmacovigilance and safety assessments
  • Investigations of drug utilization
  • Risk-benefit appraisals
  • Bayesian, meta-analytic and systematic reviews
  • Patient and clinician preferences
  • Global marketplace and pharmaceutical policy
  • Design and conduct of sophisticated comparative effectiveness, pharmacovigilance, and drug utilization studies
  • Advanced techniques for causal inference, management of missing data, and other statistical analysis
  • Cost-benefit analysis and cost-effectiveness analysis
  • Natural history of disease and resource utilization
  • Systematic economic and quality-of-life reviews
  • Core value dossiers

MA in the News

February 23, 2021
Monument Analytics: Bill Padula, Natalie Reid, Jon Tierce

Monument Analytics team members co-authored a Value & Outcomes Spotlight titled: “Health Technology Assessment for COVID-19 Treatments and Vaccines: Will Cost-Effectiveness Analysis Serve Our Needs?

February 9, 2021
Bill Padula
Monument Analytics Principal Dr. Bill Padula and Advisory Board Member Dr. Mark Sculpher co-authored a white paper titled: “Health Technology Assessment in the U.S. a Vision for the Future” as part of the USC Schaeffer Center – Aspen Institute Advisory Panel on Health Technology Assessment in the U.S.

February 4, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Financial Times article titled: “Opioid crisis haunts frontrunner for top job at US drugs regulator” for his perspectives regarding the FDA’s role in the opioid epidemic.

January 30, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in a Bloomberg News article titled: “Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight” for his views regarding the regulatory review of aducanumab.

January 20, 2021
Bill Padula
Monument Analytics Principal Dr. Bill Padula was elected 2021 President of the National Pressure Injury Advisory Panel.

January 2, 2021
Caleb Alexander

Monument Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in The Economist titled: “The other epidemic: The Justice Department accuses Walmart of fuelling the opioid crisis.” The article discussed the severity of the ongoing opioid epidemic.

SEE ALL NEWS